Galovan Scott Michael (CIK 2082926) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-28). Recent activity: Sell AVNS (135,596 shares), Buy AVNS (96,121 shares), Sell AVNS (96,121 shares), Sell AVNS (4,228 shares), Buy AVNS (29,481 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 135,596 | $3.4M |
| 2026-07-28 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Buy | 96,121 | $0 |
| 2026-07-28 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 96,121 | $2.4M |
| 2026-04-24 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 4,228 | $104,178 |
| 2026-03-17 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Buy | 29,481 | $0 |
| 2026-03-11 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 1,119 | $14,872 |
| 2026-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Buy | 5,907 | $81,458 |
| 2026-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 2,356 | $32,489 |
| 2026-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 1,057 | $14,576 |
| 2026-03-10 | AVANOS MEDICAL, INC. (AVNS) | SVP, Chief Financial Officer | Sell | 2,041 | $28,145 |
Source: SEC Form 4 filings · as of 2026-07-28